Arrow Financial’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.07M | Sell |
8,737
-329
| -4% | -$117K | 0.31% | 52 |
|
|
2025
Q4 | $2.97M | Sell |
9,066
-715
| -7% | -$227K | 0.3% | 55 |
|
|
2025
Q3 | $2.76M | Sell |
9,781
-228
| -2% | -$66.1K | 0.28% | 57 |
|
|
2025
Q2 | $2.79M | Sell |
10,009
-813
| -8% | -$230K | 0.29% | 56 |
|
|
2025
Q1 | $3.37M | Sell |
10,822
-4,775
| -31% | -$1.41M | 0.38% | 46 |
|
|
2024
Q4 | $4.07M | Buy |
15,597
+909
| +6% | +$270K | 0.39% | 58 |
|
|
2024
Q3 | $4.73M | Buy |
14,688
+1,623
| +12% | +$531K | 0.44% | 51 |
|
|
2024
Q2 | $4.08M | Buy |
13,065
+3,524
| +37% | +$1.04M | 0.4% | 54 |
|
|
2024
Q1 | $2.71M | Sell |
9,541
-1,033
| -10% | -$302K | 0.27% | 67 |
|
|
2023
Q4 | $3.05M | Sell |
10,574
-280
| -3% | -$76.3K | 0.32% | 62 |
|
|
2023
Q3 | $2.92M | Sell |
10,854
-4,530
| -29% | -$1.13M | 0.34% | 63 |
|
|
2023
Q2 | $3.42M | Sell |
15,384
-35
| -0.2% | -$8.12K | 0.41% | 59 |
|
|
2023
Q1 | $3.73M | Sell |
15,419
-135
| -0.9% | -$33.1K | 0.49% | 58 |
|
|
2022
Q4 | $4.08M | Sell |
15,554
-1,705
| -10% | -$457K | 0.55% | 48 |
|
|
2022
Q3 | $3.89M | Hold |
17,259
| – | – | 0.57% | 44 |
|
|
2022
Q2 | $4.2M | Sell |
17,259
-370
| -2% | -$90.7K | 0.57% | 41 |
|
|
2022
Q1 | $4.26M | Sell |
17,629
-175
| -1% | -$40.2K | 0.51% | 45 |
|
|
2021
Q4 | $4M | Sell |
17,804
-1,809
| -9% | -$382K | 0.47% | 48 |
|
|
2021
Q3 | $4.17M | Sell |
19,613
-844
| -4% | -$194K | 0.54% | 41 |
|
|
2021
Q2 | $4.99M | Sell |
20,457
-280
| -1% | -$68.9K | 0.63% | 37 |
|
|
2021
Q1 | $5.16M | Sell |
20,737
-72
| -0.3% | -$17.2K | 0.68% | 34 |
|
|
2020
Q4 | $4.78M | Sell |
20,809
-1,221
| -6% | -$282K | 0.93% | 31 |
|
|
2020
Q3 | $5.6M | Sell |
22,030
-275
| -1% | -$68.1K | 1.18% | 21 |
|
|
2020
Q2 | $5.26M | Sell |
22,305
-140
| -0.6% | -$31.9K | 1.15% | 20 |
|
|
2020
Q1 | $4.55M | Sell |
22,445
-368
| -2% | -$80.4K | 1.08% | 22 |
|
|
2019
Q4 | $5.5M | Sell |
22,813
-910
| -4% | -$201K | 1.07% | 21 |
|
|
2019
Q3 | $4.59M | Sell |
23,723
-2,780
| -10% | -$534K | 0.95% | 25 |
|
|
2019
Q2 | $4.88M | Sell |
26,503
-407
| -2% | -$72.9K | 1.05% | 24 |
|
|
2019
Q1 | $5.11M | Buy |
26,910
+175
| +0.7% | +$33.4K | 1.18% | 22 |
|
|
2018
Q4 | $5.2M | Buy |
26,735
+1,505
| +6% | +$294K | 1.33% | 16 |
|
|
2018
Q3 | $5.23M | Buy |
25,230
+54
| +0.2% | +$10.6K | 1.1% | 21 |
|
|
2018
Q2 | $4.65M | Sell |
25,176
-296
| -1% | -$52.4K | 1.04% | 24 |
|
|
2018
Q1 | $4.34M | Sell |
25,472
-199
| -0.8% | -$36.5K | 1.01% | 25 |
|
|
2017
Q4 | $4.46M | Sell |
25,671
-245
| -0.9% | -$43.4K | 1.03% | 24 |
|
|
2017
Q3 | $4.83M | Sell |
25,916
-337
| -1% | -$59.7K | 1.15% | 20 |
|
|
2017
Q2 | $4.52M | Sell |
26,253
-692
| -3% | -$113K | 1.08% | 22 |
|
|
2017
Q1 | $4.42M | Sell |
26,945
-485
| -2% | -$80.6K | 1.08% | 21 |
|
|
2016
Q4 | $4.01M | Sell |
27,430
-464
| -2% | -$69.8K | 0.99% | 24 |
|
|
2016
Q3 | $4.65M | Buy |
27,894
+42
| +0.2% | +$7.1K | 1.18% | 20 |
|
|
2016
Q2 | $4.24M | Sell |
27,852
-295
| -1% | -$45.9K | 1.11% | 23 |
|
|
2016
Q1 | $4.22M | Buy |
28,147
+357
| +1% | +$53K | 1.12% | 25 |
|
|
2015
Q4 | $4.51M | Buy |
27,790
+129
| +0.5% | +$20.3K | 1.2% | 24 |
|
|
2015
Q3 | $3.83M | Buy |
27,661
+227
| +0.8% | +$35.8K | 1.09% | 24 |
|
|
2015
Q2 | $4.21M | Buy |
27,434
+2,311
| +9% | +$370K | 1.14% | 26 |
|
|
2015
Q1 | $4.02M | Sell |
25,123
-413
| -2% | -$65K | 1.08% | 26 |
|
|
2014
Q4 | $4.07M | Buy |
25,536
+3,628
| +17% | +$565K | 1.11% | 24 |
|
|
2014
Q3 | $3.08M | Buy |
21,908
+860
| +4% | +$112K | 0.85% | 36 |
|
|
2014
Q2 | $2.49M | Sell |
21,048
-15
| -0.1% | -$1.74K | 0.67% | 45 |
|
|
2014
Q1 | $2.6M | Buy |
21,063
+80
| +0.4% | +$9.7K | 0.74% | 42 |
|
|
2013
Q4 | $2.39M | Buy |
20,983
+170
| +0.8% | +$19.3K | 0.69% | 49 |
|
|
2013
Q3 | $2.33M | Buy |
20,813
+35
| +0.2% | +$3.79K | 0.72% | 48 |
|
|
2013
Q2 | $2.05M | Buy |
+20,778
| New | +$2.16M | 0.66% | 48 |
|
Other funds holding AMGN
VCM
VPM
Arrow Financial's AMGN Position: Q1 2026 in Review
Arrow Financial reduced its Amgen (AMGN) stake by 3.6% in Q1 2026, selling an estimated $117K and leaving 8,737 shares worth $3.07M. The position accounts for 0.31% of the portfolio, ranked #52.
Arrow Financial first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.6M in Q3 2020. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Arrow Financial held 8,737 shares of Amgen worth $3.07M as of Q1 2026.
- Arrow Financial sold 329 Amgen shares in Q1 2026, an estimated $117K.
- Amgen made up 0.31% of Arrow Financial's portfolio in Q1 2026, its #52 holding.
- Arrow Financial first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- Arrow Financial's Amgen position peaked at $5.6M in Q3 2020.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Arrow Financial's 13F filing for Q1 2026, filed 11 May 2026.